Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine
Clinical trial NCT02842853 · COMPLETED
Trial details
- NCT number
- NCT02842853
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-15
- Primary completion
- 2017-02-28
- Enrollment
- 3344
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.